Hill Pharmaceutical owns multiple provincial research platforms. Our R&D team of over 20 staff includes 5 PhDs and 3 experts, with annual R&D investment above 6% of revenue. Since 2004, we have cooperated with top universities and research institutes. We hold PCT patents for mulberry leaf extract and led relevant international industry standards.

Our Yongzhou production base has an annual raw material capacity of 10,000 tons, equipped with full production lines and advanced German equipment. With an industry-university-research closed-loop system, we apply AI smart production, IoT monitoring and digital quality control to raise extraction efficiency and shorten test cycles, delivering stable large-scale supply worldwide.